Sagimet Biosciences Inc. (SGMT)
NASDAQ: SGMT · Real-Time Price · USD
4.120
+0.095 (2.36%)
Feb 21, 2025, 4:00 PM EST - Market closed
Sagimet Biosciences Market Cap
Sagimet Biosciences has a market cap or net worth of $132.64 million as of February 21, 2025. Its market cap has decreased by -34.51% in one year.
Market Cap
132.64M
Enterprise Value
-37.20M
1-Year Change
-34.51%
Ranking
Category
Stock Price
$4.12
Market Cap Chart
Since the IPO on July 14, 2023, Sagimet Biosciences's market cap has decreased from $354.80M to $132.64M, a decrease of -62.61%. That is a compound annual growth rate of -45.70%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 21, 2025 | 132.64M | -8.44% |
| Dec 31, 2024 | 144.88M | 16.75% |
| Dec 29, 2023 | 124.10M | -65.02% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 785.00B |
| UnitedHealth Group | 428.62B |
| Johnson & Johnson | 390.92B |
| Novo Nordisk | 370.84B |
| AbbVie | 356.85B |
| Abbott Laboratories | 234.05B |
| AstraZeneca | 229.50B |
| Merck & Co. | 226.40B |